These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dynamic MRI of bladder cancer: evaluation of staging accuracy. Tekes A; Kamel I; Imam K; Szarf G; Schoenberg M; Nasir K; Thompson R; Bluemke D AJR Am J Roentgenol; 2005 Jan; 184(1):121-7. PubMed ID: 15615961 [TBL] [Abstract][Full Text] [Related]
3. Preoperative T staging of urinary bladder cancer: does diffusion-weighted MRI have supplementary value? Watanabe H; Kanematsu M; Kondo H; Goshima S; Tsuge Y; Onozuka M; Moriyama N AJR Am J Roentgenol; 2009 May; 192(5):1361-6. PubMed ID: 19380561 [TBL] [Abstract][Full Text] [Related]
4. Dynamic gadolinium-enhanced magnetic resonance imaging in staging of superficial bladder cancer. Scattoni V; Da Pozzo LF; Colombo R; Nava L; Rigatti P; De Cobelli F; Vanzulli A; Del Maschio A J Urol; 1996 May; 155(5):1594-9. PubMed ID: 8627831 [TBL] [Abstract][Full Text] [Related]
5. Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted MRI with gadolinium-enhanced MRI using liver explantation standard. Hardie AD; Kizziah MK; Rissing MS J Comput Assist Tomogr; 2011; 35(6):711-5. PubMed ID: 22082541 [TBL] [Abstract][Full Text] [Related]
6. [Preoperative staging of bladder carcinomas with Gd-DTPA-supported dynamic magnetic resonance tomography. Comparison with plain and Gd-DTPA-supported spin-echo sequences]. Venz S; Hosten N; Ilg J; Mäurer J; Podrabsky P; Fedel M; Ebert T; Nagel R Rofo; 1996 Mar; 164(3):218-25. PubMed ID: 8672777 [TBL] [Abstract][Full Text] [Related]
7. Preoperative staging of invasive bladder cancer with dynamic gadolinium-enhanced magnetic resonance imaging: results from a prospective study. Daneshmand S; Ahmadi H; Huynh LN; Dobos N Urology; 2012 Dec; 80(6):1313-8. PubMed ID: 23040723 [TBL] [Abstract][Full Text] [Related]
8. [Determining the depth of infiltration in urinary bladder carcinoma with contrast medium enhanced dynamic magnetic resonance tomography. With reference to postoperative findings and inflammation]. Venz S; Ilg J; Ebert T; Hierholzer J; Friedrichs R; Hosten N; Felix R Urologe A; 1996 Jul; 35(4):297-304. PubMed ID: 8928358 [TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience. El-Assmy A; Abou-El-Ghar ME; Refaie HF; Mosbah A; El-Diasty T BJU Int; 2012 Dec; 110(11 Pt B):E622-7. PubMed ID: 22757606 [TBL] [Abstract][Full Text] [Related]
10. Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade. Takeuchi M; Sasaki S; Ito M; Okada S; Takahashi S; Kawai T; Suzuki K; Oshima H; Hara M; Shibamoto Y Radiology; 2009 Apr; 251(1):112-21. PubMed ID: 19332849 [TBL] [Abstract][Full Text] [Related]
11. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer. Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184 [TBL] [Abstract][Full Text] [Related]
12. Value of MRI in local staging of bladder cancer. Ghafoori M; Shakiba M; Ghiasi A; Asvadi N; Hosseini K; Alavi M Urol J; 2013; 10(2):866-72. PubMed ID: 23801469 [TBL] [Abstract][Full Text] [Related]
13. Clinical value of T2-weighted imaging combined with diffusion-weighted imaging in preoperative T staging of urinary bladder cancer: a large-scale, multiobserver prospective study on 3.0-T MRI. Wu LM; Chen XX; Xu JR; Zhang XF; Suo ST; Yao QY; Fan Y; Hu J Acad Radiol; 2013 Aug; 20(8):939-46. PubMed ID: 23746384 [TBL] [Abstract][Full Text] [Related]
14. Staging urinary bladder cancer after transurethral biopsy: value of fast dynamic contrast-enhanced MR imaging. Barentsz JO; Jager GJ; van Vierzen PB; Witjes JA; Strijk SP; Peters H; Karssemeijer N; Ruijs SH Radiology; 1996 Oct; 201(1):185-93. PubMed ID: 8816542 [TBL] [Abstract][Full Text] [Related]
15. Preoperative magnetic resonance staging of rectal cancer with an endorectal coil and dynamic gadolinium enhancement. Drew PJ; Farouk R; Turnbull LW; Ward SC; Hartley JE; Monson JR Br J Surg; 1999 Feb; 86(2):250-4. PubMed ID: 10100797 [TBL] [Abstract][Full Text] [Related]
16. Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature. Giannarini G; Petralia G; Thoeny HC Eur Urol; 2012 Feb; 61(2):326-40. PubMed ID: 22000497 [TBL] [Abstract][Full Text] [Related]
17. Combined T2-weighted and diffusion-weighted MRI for diagnosis of urinary bladder invasion in patients with prostate carcinoma. Ren J; Huan Y; Li F; Wang H; Ge Y; Chang Y; Yin H; Sun L J Magn Reson Imaging; 2009 Aug; 30(2):351-6. PubMed ID: 19591203 [TBL] [Abstract][Full Text] [Related]
18. Utility of quantitative MRI metrics for assessment of stage and grade of urothelial carcinoma of the bladder: preliminary results. Rosenkrantz AB; Haghighi M; Horn J; Naik M; Hardie AD; Somberg MB; Melamed J; Xiao GQ; Huang WC; Taouli B AJR Am J Roentgenol; 2013 Dec; 201(6):1254-9. PubMed ID: 24261364 [TBL] [Abstract][Full Text] [Related]
19. Multiparametric 3-T MRI for differentiating low-versus high-grade and category T1 versus T2 bladder urothelial carcinoma. Wang HJ; Pui MH; Guo Y; Li SR; Guan J; Zhang XL; Cai HS AJR Am J Roentgenol; 2015 Feb; 204(2):330-4. PubMed ID: 25615755 [TBL] [Abstract][Full Text] [Related]
20. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis. Xu PJ; Yan FH; Wang JH; Lin J; Ji Y J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]